Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Clinical trial NCT03449199 · COMPLETED

Trial details

NCT number: NCT03449199
Sponsor: Teijin America, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Kidney Disease

Start date: 2018-04-10
Primary completion: 2019-05-07
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.